Scarica l'app Stockscreener
75.26
2.90%
2.12
Dopo l'orario di chiusura:
74.97
-0.29
-0.39%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Henry Schein Inc Borsa (HSIC) Ultime notizie
United States Personal Protective Equipment (Gowns, Masks, Face Shields and Others) Market Outlook to 2033 - GlobeNewswire Inc.
Henry Schein, Inc. $HSIC Shares Sold by Strs Ohio - MarketBeat
Henry Schein (BIT:1HSIC) Price Target Decreased by 12.37% to 65.12 - Nasdaq
What Henry Schein (HSIC)'s Activist-Backed Governance Shift and CEO Transition Means For Shareholders - Yahoo Finance
Greenlight Capital Backs Henry Schein As Governance Shifts Target Margins - Yahoo Finance
Assessing Henry Schein’s Valuation After Greenlight Capital’s Push For Operational Improvements - Sahm
How Henry Schein Inc. (HSIC) Affects Rotational Strategy Timing - Stock Traders Daily
Does Henry Schein (HSIC) Have Potential for Margin Improvement and Increased Shareholder Value? - Insider Monkey
Henry Schein, Inc. $HSIC Holdings Lowered by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Briefly: NCPA, Henry Schein Announce New Executive Leaders - HME Business
Analyst Downgrade: Will Henry Schein Inc. benefit from green energy policiesEarnings Beat & Expert Approved Trade Ideas - baoquankhu1.vn
Henry Schein Schedules Q4 2025 Earnings Call - Dentistry Today
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Agios Pharma (AGIO) and Henry Schein (HSIC) - The Globe and Mail
Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET - BioSpace
How Investors Are Reacting To Henry Schein (HSIC) New CEO Pick And Exclusive CitoCBC Deal - simplywall.st
Henry Schein Shares Consolidate as Technical and Fundamental Catalysts Align - AD HOC NEWS
Henry Schein Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Dilation Capital Management LP Invests $5.11 Million in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Names Frederick M. Lowery as Chief Executive Officer - Zenopa
Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Henry Schein Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途资讯
The Truth About Henry Schein Inc: Why Wall Street Is Watching (But TikTok Barely Cares…Yet) - AD HOC NEWS
Mizuho Adjusts Price Target on Henry Schein to $81 From $74, Maintains Neutral Rating - marketscreener.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Here's What to Expect From Henry Schein's Next Earnings Report - Yahoo Finance
Analysts Are Bullish on These Healthcare Stocks: Henry Schein (HSIC), Boston Scientific (BSX) - The Globe and Mail
Mixed Strategic Drivers Led Upslope Capital Management to Pick Henry Schein (HSIC) - Insider Monkey
Tetratherix executes global distribution & supply agreement with Henry Schein - marketscreener.com
Tetratherix Executes Global Distribution & Supply Agreement With Henry Schein - TradingView — Track All Markets
Newly listed biotech Tetratherix secures global distribution deal with US giant Henry Schein - Business News Australia
Australia's Tetratherix hits four-week high on supply deal with Henry Schein - TradingView — Track All Markets
Henry Schein (NASDAQ:HSIC) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Henry Schein names new CEO - DrBicuspid.com
Henry Schein (HSIC) Valuation Check After Exclusive CitoCBC Distribution Agreement - Yahoo Finance
Henry Schein inks exclusive U.S. distribution deal for CLIA-waived CBC system - Medical Economics
Henry Schein enters distribution agreement for CytoChip's CLIA-waived hematology analyzer - marketscreener.com
Henry Schein Enters Distribution Agreement For CytoChip’S CLIA-Waived Hematology Analyzer - TradingView — Track All Markets
Henry Schein Agrees to Distribute CytoChip's CitoCBC system - marketscreener.com
Henry Schein (HSIC) Partners with CytoChip for Exclusive Distrib - GuruFocus
Henry Schein to distribute FDA-cleared blood test system nationwide - Investing.com
Henry Schein to distribute FDA-cleared blood test system nationwide By Investing.com - Investing.com South Africa
Henry Schein Enters Exclusive Distribution Agreement for CytoChip’s CLIA-Waived Hematology Analyzer - joplinglobe.com
Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer - Quantisnow
3 Reasons to Sell HSIC and 1 Stock to Buy Instead - Yahoo Finance
Henry Schein names a new CEO - Digital Commerce 360
JPM26: Henry Schein focuses on high-margin, high-growth business as new CEO announced - Yahoo Finance
Henry Schein extends private placement facilities to 2028 - MSN
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term - sharewise.com
Henry Schein Seeks M&A Opportunities - marketscreener.com
Henry Schein Taps Former Thermo Fisher Exec as New CEO - Modern Distribution Management
Will Henry Schein’s (HSIC) New External CEO and Governance Shift Reframe Its Leadership Narrative? - simplywall.st
Henry Schein Names Thermo Fisher Exec Fred Lowery as CEO - Medical Product Outsourcing
Frederick Lowery named new CEO of Henry Schein, effective March 2026 - Investing.com Nigeria
Henry Schein appoints Frederick Lowery as CEO - MSN
Leadership transition at Henry Schein: Frederick M. Lowery to take over as CEO - Dental Tribune US
Henry Schein names Frederick M. Lowery as new CEO - newsday.com
9.59%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):